1 History and development

IVF emerged from decades of reproductive biology research and clinical experimentation. Its development brought together advances in endocrinology, embryology, surgery, and laboratory culture, gradually transforming a laboratory concept into a widely used fertility treatment.

1.1 Early experiments in fertilization

Early studies in mammalian reproduction established that eggs could be removed, fertilized outside the body, and then observed during early development. Researchers refined methods for handling gametes, maintaining them in culture, and identifying conditions that supported embryonic growth. These experiments created the scientific foundation for later human application.

1.2 Clinical breakthroughs

The first successful human IVF births demonstrated that embryos created in the laboratory could implant in the uterus and result in live birth. Improvements in ultrasound guidance, hormone treatment, and embryo culture later increased reliability and safety. These milestones helped define IVF as a practical medical procedure rather than an experimental technique.

1.3 Expansion of assisted reproductive technology

As IVF became established, it expanded into a broader group of assisted reproductive technologies. Related methods such as intracytoplasmic sperm injection, cryopreservation, and preimplantation genetic testing broadened treatment options. IVF also became integrated with fertility preservation and donor-based reproduction, increasing its role in modern reproductive medicine.

2 Indications for use

IVF is used when natural conception is unlikely, delayed, or medically inadvisable. It may also be chosen to reduce the risk of passing on certain inherited conditions or to preserve reproductive potential before treatment that could impair fertility.

2.1 Tubal factor infertility

When the fallopian tubes are blocked, damaged, or absent, fertilization in the body may not occur normally. IVF bypasses the tubes by placing embryos directly into the uterus. This makes it especially useful after pelvic infection, surgery, or tubal sterilization reversal is not feasible.

2.2 Male factor infertility

IVF can help when sperm count, motility, morphology, or transport is impaired. In some cases conventional insemination is sufficient; in others, intracytoplasmic sperm injection is used to place a single sperm directly into an egg. This approach can overcome many severe sperm-related barriers.

2.3 Ovulatory disorders

People with irregular or absent ovulation may have difficulty timing conception. IVF allows controlled stimulation of the ovaries and retrieval of multiple eggs in one cycle. It is often considered when medication alone has not produced consistent ovulation or pregnancy.

2.4 Unexplained infertility

Some couples experience infertility despite normal evaluation results. IVF may be used after less invasive treatments have failed or when time is a concern. In such cases, IVF can both assist conception and provide additional information about egg, sperm, and embryo behavior.

2.5 Genetic disease prevention

IVF can be combined with preimplantation genetic testing to reduce the chance of transferring embryos affected by certain inherited disorders. This is especially relevant when one or both genetic parents carry a known pathogenic variant or chromosomal rearrangement. The method supports reproductive planning while limiting the risk of transmission.

2.6 Fertility preservation

IVF-related techniques are used to preserve fertility before medical treatments such as chemotherapy, radiation, or surgery that may damage reproductive organs. Eggs or embryos may be frozen for later use. Fertility preservation is also considered for people who wish to delay childbearing for personal or medical reasons.

3 IVF procedure

The IVF process usually includes hormonal stimulation, egg retrieval, laboratory fertilization, embryo development, and embryo transfer. Some cycles involve freezing surplus embryos for future use, while others proceed with a fresh transfer.

3.1 Ovarian stimulation

Medications are given to encourage the ovaries to produce multiple mature follicles rather than a single egg. This increases the number of eggs available for retrieval and may improve the chance of obtaining viable embryos. Stimulation protocols are tailored to age, diagnosis, and ovarian response.

3.2 Monitoring and trigger injection

During stimulation, ultrasound and hormone measurements are used to assess follicle growth and timing. When follicles are ready, a trigger medication promotes final egg maturation. Accurate timing is important because retrieval must occur before spontaneous ovulation.

3.3 Egg retrieval

Egg retrieval is typically performed with a needle guided by transvaginal ultrasound. The procedure is brief and usually done under sedation or anesthesia. Follicular fluid is collected and examined in the laboratory for mature eggs.

3.4 Sperm collection and preparation

Sperm is usually obtained from a semen sample, though surgical retrieval may be needed in selected cases. Laboratory processing concentrates motile sperm and removes debris or excess fluid. Preparation methods are chosen according to semen quality and the planned fertilization technique.

3.5 Fertilization in the laboratory

Retrieved eggs and prepared sperm are combined in controlled laboratory conditions. Fertilization may occur through standard insemination or with micromanipulation techniques. The method selected depends on sperm factors, prior fertilization history, and laboratory strategy.

3.5.1 Conventional insemination

In conventional insemination, sperm and eggs are placed together in culture media and fertilization occurs naturally in vitro. This approach relies on sperm to penetrate the egg on its own. It is often used when semen parameters are adequate.

3.5.2 Intracytoplasmic sperm injection

Intracytoplasmic sperm injection involves injecting one sperm directly into an egg. It is especially useful for severe male factor infertility or previous fertilization failure. The technique bypasses several steps of natural fertilization and can improve the chance that an egg fertilizes.

3.6 Embryo culture

After fertilization, embryos are cultured for several days while embryologists monitor development. The laboratory evaluates cell division, symmetry, and progression to the blastocyst stage. Culture conditions are designed to support embryo development while allowing selection of embryos for transfer or freezing.

3.7 Embryo transfer

Embryo transfer places one or more embryos into the uterus using a thin catheter. The procedure is usually simple and does not require anesthesia. The number of embryos transferred is chosen to balance pregnancy chances with the risk of multiple gestation.

3.8 Luteal phase support

After transfer, hormone support is commonly provided to help the uterine lining remain receptive. Progesterone is the most frequently used medication. Support may continue until pregnancy testing and, if conception occurs, through early gestation depending on clinic protocol.

4 Laboratory techniques and technologies

Laboratory methods play a central role in IVF outcomes. These tools help embryologists assess embryo quality, preserve reproductive cells, and identify embryos with specific genetic concerns.

4.1 Embryo grading

Embryo grading is the visual assessment of embryo appearance and developmental stage. Features such as cell number, fragmentation, symmetry, and blastocyst expansion may be considered. Grading helps guide selection, although it does not guarantee implantation or predict every aspect of outcome.

4.2 Time-lapse embryo imaging

Time-lapse systems photograph embryos at frequent intervals without removing them from the incubator. This creates a continuous developmental record and may assist in identifying normal patterns of cleavage and growth. The method can improve observation while minimizing disturbance to culture conditions.

4.3 Cryopreservation

Cryopreservation is the storage of eggs, embryos, or sperm at very low temperatures for later use. Vitrification, a rapid freezing method, is widely used because it helps reduce ice-crystal formation. Cryopreservation supports fertility preservation, staged treatment, and transfer at a later time.

4.3.1 Egg freezing

Egg freezing allows unfertilized eggs to be stored for future fertilization. It is used for fertility preservation and in situations where embryo creation is not immediately possible. Success depends on age at freezing, egg number, and laboratory technique.

4.3.2 Embryo freezing

Embryo freezing stores fertilized embryos for later transfer. This approach is common when excess embryos remain after a cycle or when a fresh transfer is not ideal. Frozen embryos may be used in subsequent cycles without repeating egg retrieval.

4.4 Preimplantation genetic testing

Preimplantation genetic testing examines embryos for selected genetic or chromosomal conditions before transfer. It may be used to identify embryos affected by specific inherited disorders or those with chromosomal abnormalities. The test can guide transfer decisions but does not replace prenatal diagnosis in all cases.

5 Success rates and outcomes

IVF success varies widely from person to person and cycle to cycle. Outcomes are influenced by age, diagnosis, laboratory quality, and whether fresh or frozen transfer is used. Clinicians often discuss both per-cycle and cumulative chances.

5.1 Factors affecting success

Several biological and technical factors influence IVF outcome. These include ovarian response, egg and sperm quality, embryo development, uterine receptivity, and laboratory expertise. The combined effect of these variables makes individual prediction difficult.

5.1.1 Maternal age

Age is one of the strongest predictors of IVF success. Fertility generally declines with increasing age because egg quantity and quality decrease over time. Older age is also associated with a higher risk of chromosomal abnormalities in embryos.

5.1.2 Embryo quality

Embryos with favorable developmental features are more likely to implant and continue developing. Quality is assessed by morphology, timing, and sometimes genetic testing. Even among high-grade embryos, implantation remains probabilistic rather than certain.

5.1.3 Cause of infertility

The underlying cause of infertility affects the likelihood of success. Tubal disease, male factor infertility, uterine abnormalities, and diminished ovarian reserve each present different challenges. Some causes are more responsive to IVF than others, especially when the problem can be bypassed rather than corrected.

5.2 Live birth rates

Live birth rate is the most meaningful measure of IVF success because it reflects delivery of a living infant. Rates are commonly reported per cycle started, per egg retrieval, or per embryo transfer. These numbers vary by clinic, patient population, and treatment approach.

5.3 Multiple pregnancy risk

Transfer of more than one embryo increases the chance of twins or higher-order multiples. Multiple pregnancy can raise maternal and neonatal risks, so many clinics favor single-embryo transfer when appropriate. Careful embryo selection has helped reduce this complication.

5.4 Cumulative outcomes across cycles

A single IVF cycle may not produce pregnancy, but the chance of success can improve across repeated attempts or when frozen embryos are available. Cumulative outcomes consider all embryos derived from one retrieval or several linked cycles. This perspective often gives a more complete estimate of overall treatment value.

6 Risks and complications

IVF is generally safe, but it involves medical procedures and hormone use that can cause complications. Risks may arise during stimulation, egg retrieval, pregnancy, or embryo transfer.

6.1 Ovarian hyperstimulation syndrome

Ovarian hyperstimulation syndrome occurs when the ovaries respond excessively to fertility medications. Symptoms can range from bloating and discomfort to more severe fluid shifts and abdominal pain. Modern protocols and monitoring have reduced the frequency of serious cases.

Egg retrieval can occasionally cause bleeding, infection, or injury to nearby structures. Embryo transfer is usually low risk, though cramping or spotting may occur. Careful technique and sterile procedures help limit these problems.

6.3 Ectopic pregnancy

In some cases an embryo implants outside the uterus, most often in a fallopian tube. This is a medical emergency if it progresses and can threaten maternal health. Early ultrasound and hormone testing help detect abnormal implantation.

6.4 Miscarriage

Miscarriage can occur after IVF just as in natural conception. Risk is influenced by age, embryo genetics, and underlying health conditions. IVF does not eliminate miscarriage, though genetic testing may reduce the transfer of embryos with certain chromosomal abnormalities.

6.5 Multiple gestation complications

Pregnancies with twins or more carry higher risks of preterm birth, low birth weight, and pregnancy-related complications. The chance of such outcomes rises when multiple embryos are transferred. For this reason, single-embryo transfer is often encouraged when feasible.

IVF raises questions about embryo status, parental rights, donor involvement, and access to care. These issues vary by jurisdiction and are shaped by medical, legal, and personal values.

7.1 Embryo disposition

Unused frozen embryos may be stored, donated, discarded, or used for research depending on regulations and patient preference. Decisions about disposition can be emotionally complex because embryos may have personal or symbolic significance. Clinics typically ask patients to make plans in advance.

7.2 Donor gametes

Egg donation and sperm donation are used when a patient cannot produce usable gametes or prefers donor assistance. Donor conception introduces questions of anonymity, disclosure, and family planning. Legal parentage and recordkeeping depend on local rules and clinic policy.

IVF may be part of gestational surrogacy, in which another person carries the pregnancy. This arrangement can help individuals who cannot safely carry a pregnancy themselves. It also requires clear agreements regarding consent, medical care, and parental responsibilities.

7.4 Access and cost

IVF can be expensive and may require multiple cycles, making access uneven. Coverage policies, clinic availability, and local regulation influence who can receive treatment. Cost considerations often affect decisions about stimulation protocols, freezing, genetic testing, and number of embryos transferred.

Several IVF variants adjust stimulation intensity, gamete source, or transfer timing. These approaches aim to fit treatment to medical needs, preferences, and practical constraints.

8.1 Natural-cycle IVF

Natural-cycle IVF retrieves the single egg produced in a spontaneous menstrual cycle without heavy ovarian stimulation. It reduces medication exposure but usually yields fewer eggs. The method may be considered for selected patients who wish to avoid stimulation drugs or cannot use them.

8.2 Mild stimulation IVF

Mild stimulation IVF uses lower doses of medication than conventional protocols. It seeks a balance between egg yield and treatment burden. This approach may be suitable for some patients who prefer a less intensive regimen.

8.3 Donor egg IVF

In donor egg IVF, eggs from another person are fertilized and transferred to the recipient. This can help when ovarian reserve is very low, age-related egg quality has declined, or inherited disease risk is a concern. Pregnancy outcomes may be influenced more by embryo quality than by the recipient’s own egg supply.

8.4 Donor sperm IVF

Donor sperm IVF uses sperm from a screened donor rather than a partner. It may be chosen when there is severe male factor infertility, absence of sperm, or a need to avoid transmission of a known genetic condition. The donor sample may be used with IVF or insemination depending on the clinical situation.

8.5 Frozen embryo transfer

Frozen embryo transfer involves thawing a previously stored embryo and placing it into the uterus in a later cycle. Timing can be aligned with the uterine lining and hormone levels. Many clinics use this approach routinely because frozen transfer can be efficient and flexible.

8.6 Reciprocal IVF

Reciprocal IVF is used by some couples in which both partners have a reproductive role, with one providing eggs and the other carrying the pregnancy. It allows shared participation in conception and gestation. The arrangement is often chosen for personal, relational, or medical reasons.

9 Aftercare and counseling

Care after IVF includes pregnancy assessment, medical follow-up, and emotional support. Counseling helps patients interpret results and plan next steps, whether the cycle is successful or not.

9.1 Pregnancy testing

Pregnancy is usually checked with a blood test for human chorionic gonadotropin after embryo transfer. Repeat testing may be used to confirm that hormone levels are rising appropriately. If positive, ultrasound later helps verify location and viability.

9.2 Follow-up after transfer

After transfer, patients are monitored for medication tolerance, early pregnancy symptoms, and signs of complication. Instructions often cover activity, medication use, and when to seek urgent care. Follow-up may continue until pregnancy is confirmed or the cycle ends.

9.3 Emotional and psychological support

IVF can be emotionally demanding because it involves uncertainty, repeated procedures, and possible disappointment. Support may include counseling, support groups, or communication with the care team. Psychological care is often valuable regardless of treatment outcome.

9.4 Patient education and shared decision-making

Patients benefit from clear explanations of protocol options, likely benefits, possible risks, and alternatives. Shared decision-making helps align treatment with medical findings and personal values. Good education can also improve preparedness for the physical and emotional aspects of care.